Benlysta dosing calculator

Learn about the BENLYSTA (belimumab) Vial Calculator for intravenous (IV) use. Read about BENLYSTA dosing and administration for patients with SLE.

Do not take BENLYSTA if you have an allergic reaction (hypersensitivity) to BENLYSTA or to any ingredients in it. Serious warnings and precautions for BENLYSTA. Allergic and infusion/injection reactions including anaphylaxis. BENLYSTA can cause a reaction to the infusion/injection or an allergic (hypersensitivity) reaction.

Benlysta is in the drug class selective immunosuppressants. Benlysta is used to treat the following conditions: Lupus Lupus Erythematosus Lupus Nephritis

Benlysta does not require any extra labs:​​ Like Saphnelo, Benlysta does not need additional labs to monitor side effects.

Benlysta vs Saphnelo; Benlysta vs Lupkynis; More about Benlysta More about Mycophenolate mofetil: Ratings Reviews: Benlysta has an average rating of 7.9 out of 10

including Medication Guide, for BENLYSTA and Important Facts about BENLYSTA on pages . Inspect BENLYSTA solution Look in the Inspection Window to check that the BENLYSTA solution is colorless to slightly yellow in color. It is normal to see 1 or more air bubbles in the solution. Do not use if the solution looks cloudy, discolored, or has

Patients who received placebo in BLISS-76 received 10 mg/kg BENLYSTA in the LTE study, and patients who received BENLYSTA continued to receive the same dose (1 or 10 mg/kg IV every 28 days) plus standard therapy. Following a protocol amendment in March 2024, patients receiving 1 mg/kg BENLYSTA had their dose increased to 10 mg/kg.

Benlysta Infusion vs. Injection: 3 Differences To Note. Belimumab (sold under the brand name Benlysta) is a biologic drug approved by the U.S.

Benlysta and Lupkynis. New Benlysta data at EULAR demonstrated durable compared to standard dosing, and in fact other than an increase in zoster.